Lenard M Lichtenberger

This inventor holds 20 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: The University of Texas System, Other. Active years: 1990-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lenard M Lichtenberger. Retrieved from https://idiyas.com/inventor/lenard-m-lichtenberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 4)

% Patents Active = 55.0

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.1

ph-index = 9

Forward Citations = 392(Granted Patents)

Company Filing History:

19 out of 5,649

The University of Texas System

patents

1 out of 834,708

Other

patents

Years Active: 1990-2017

Loading Chart...

Areas of Expertise:

Lecithin Oils

NSAIDs

Phospholipids

Gastrointestinal Tract

Inflammatory Bowel Disease

Cancer Treatment

Therapeutic Activity

Bisphosphonates

Delivery Systems

Polar Lipids

Neutral Lipids

Organic Compounds

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9687551 - Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity (2017-06-27),

2. 9351984 - Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity (2016-05-31),

3. 9101637 - Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity (2015-08-11),

4. 8911752 - Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity (2014-12-16),

5. 8865187 - Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity (2014-10-21),

6. 8802656 - Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same (2014-08-12),

7. 8252836 - Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease (2012-08-28),

8. 7838511 - Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers (2010-11-23),

9. 7700651 - Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease (2010-04-20),

10. 7354912 - Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity (2008-04-08),

11. 6943155 - Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity (2005-09-13),

12. 5955451 - Methods of enhancing the therapeutic activity of NSAIDS and compositions (1999-09-21),

13. 5763422 - Methods of enhancing the therapeutic activity of NSAIDS and compositions (1998-06-09),

14. 5260287 - Polyphosphorylated organic compounds: compositions useful in protecting (1993-11-09),

15. 5260284 - Methods employing unique mixtures of polar and neutral lipids and sterol (1993-11-09),

Title: **Lenard M. Lichtenberger: Innovator in Pharmaceutical Compositions**

Introduction

Lenard M. Lichtenberger, based in Houston, TX, is a prominent inventor known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 20 patents, he has focused his research on developing innovative compositions that aim to enhance therapeutic activities while minimizing side effects.

Latest Patents

One of Lichtenberger's latest patents revolves around "Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity." This novel pharmaceutical composition allows for the incorporation of nonsteroidal anti-inflammatory drugs (NSAIDs) directly into phospholipid-containing oils, such as lecithin oils. The formulation boasts low gastrointestinal toxicity and enhances therapeutic activities in treating inflammation, pain, fever, platelet aggregation, and various tissue disorders. The patent describes the composition in various forms, including non-aqueous solutions, pastes, suspensions, and both aqueous emulsions and microemulsions suitable for internal, oral, direct, or topical administration.

Career Highlights

Throughout his career, Lichtenberger has been associated with esteemed institutions, including the University of Texas System and the University of Texas System Board of Regents. His work has had a meaningful impact in the pharmaceutical field, focusing on the intricate relationship between drug composition and therapeutic effectiveness.

Collaborations

In his professional journey, Lichtenberger has collaborated with talented individuals such as Bruce D. Butler and Jose C. Barreto. These partnerships have enriched his research and developments, allowing for a more profound exploration of innovative pharmaceutical solutions.

Conclusion

Lenard M. Lichtenberger exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to enhancing drug formulations demonstrates a robust understanding of the complexities involved in therapeutic compositions. With 20 patents to his name, Lichtenberger continues to be a leading figure in the quest for improved medical treatments, showcasing the vital role of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.